Fundraising Fox

Helen Liang

InvestorFounder

Founder / Managing Partner at FoundersX Ventures Β· Board director at Cognito Therapeutics Group Β· Board director at Cognito Therapeutics

Silicon Valley

About

Helen Liang founded FoundersX Ventures in 2016 with backing from a founders circle connected to Stanford, and brings more than 10 years of product experience in high-tech industries. She leads the firm's investing in enterprise AI, fintech, digital health, and biotech. She holds a PhD from the University of Wisconsin-Madison, completed the Harvard HBS PE/VC program (Class of 2022), and is a guest lecturer at Stanford.

Invests in

AI & Machine LearningBiotechDigital HealthEnterprise SoftwareFintech

Board director at Cognito Therapeutics Group

Intro paths

β†’

In turn, Helen can intro founders to Cognito Therapeutics Group's investors below.

Cognito Therapeutics Group's investors Β· 1

Board director at Cognito Therapeutics

Intro paths

β†’

In turn, Helen can intro founders to Cognito Therapeutics's investors below.

Cognito Therapeutics's investors Β· 1

Experience

  1. FoundersX VenturesFounder & Managing Partnercurrent2016 β€” presentMenlo Park
  2. World LabsInvestorcurrent2026 β€” presentSan Francisco Bay Area
  3. SpaceXInvestorcurrent2020 β€” presentLos Angeles, California, United States
  4. Turion SpaceInvestorcurrent2021 β€” presentLos Angeles Metropolitan Area
  5. Universal QuantumInvestorcurrent2020 β€” presentGreater London, England, United Kingdom
  6. Solve IntelligenceInvestorcurrent2023 β€” presentSan Francisco Bay Area
  7. FS2Investor & Board Directorcurrent2025 β€” presentBoston, Massachusetts, United States
  8. Linvest21Investor & Board Directorcurrent2023 β€” presentNew York City Metropolitan Area
  9. KapitalInvestorcurrent2022 β€” presentMexico
  10. Alinea InvestInvestorcurrent2024 β€” presentNew York City Metropolitan Area
  11. JeevesInvestorcurrent2020 β€” presentManhattan, New York, United States
  12. Salt SecurityInvestorcurrent2016 β€” presentSan Francisco Bay Area
  13. Charge RoboticsInvestorcurrent2022 β€” presentSan Francisco Bay Area
  14. Mbodi AIInvestorcurrent2025 β€” presentSan Francisco Bay Area
  15. DreamFlare AIInvestor & Board Directorcurrent2023 β€” presentLondon Area, United Kingdom
  16. Markable AIInvestor & Board Directorcurrent2021 β€” presentSan Francisco Bay Area
  17. NitraInvestorcurrent2022 β€” presentNew York City Metropolitan Area
  18. Glyphic BiotechnologiesInvestorcurrent2024 β€” presentSan Francisco Bay Area
  19. Cognito Therapeutics, Inc.Investor and Board Observercurrent2022 β€” presentSan Francisco Bay Area
  20. OmniscopeInvestor & Board Advisorcurrent2023 β€” presentSan Francisco Bay Area

Education

  1. Harvard Business SchoolCorporate Board Executive Program
  2. Stanford University Graduate School of BusinessExecutive Program, Leadership Development
  3. Harvard Business SchoolExecutive Program, Building a Legacy: Family Office Wealth Management
  4. Harvard Business SchoolExecutive Programs on PE & VC and Investment Management2022
  5. University of Wisconsin-MadisonPh.D., Materials Science and Engineering

Skills & more

Product Development94Start-ups97Entrepreneurship77Change Management10Program Management17Innovation Management5Cross-functional Team Leadership17Product Management10Project Management6Venture Capital9Business Strategy7Angel Investing3
+4 moreEnterprise SoftwareStrategic PlanningTeam LeadershipManagement

Languages English Β· German

  • Making Corporate Boards More Effective β€” Harvard Business School

From Helen's professional profile.

Deals Β· 2

Cognito Therapeutics GroupBoard seat

via FoundersX Ventures Β· filed Apr 2025 Β· $196.3M raise

Cognito TherapeuticsBoard seat

via FoundersX Ventures Β· filed Jul 2024 Β· $60M raise

Attribution from SEC filings, press coverage, and firm rosters.

Other disclosed investments

Sources: SEC Form D filings Β· the firm's website.

Colleagues at FoundersX Ventures

Network2

Investors connected to Helen in public investor directories β€” a warm-intro map.

Frequently asked questions

Who is Helen Liang?
Helen Liang founded FoundersX Ventures in 2016 with backing from a founders circle connected to Stanford, and brings more than 10 years of product experience in high-tech industries. She leads the firm's investing in enterprise AI, fintech, digital health, and biotech. She holds a PhD from the University of Wisconsin-Madison, completed the Harvard HBS PE/VC program (Class of 2022), and is a guest lecturer at Stanford.
Where does Helen Liang work?
Helen Liang is Founder / Managing Partner at FoundersX Ventures and Board director at Cognito Therapeutics Group and Board director at Cognito Therapeutics.
What does Helen Liang invest in?
Helen Liang invests in AI & Machine Learning, Biotech, Digital Health, Enterprise Software, Fintech.
What boards does Helen Liang sit on?
Helen Liang holds tracked board seats at Cognito Therapeutics, Cognito Therapeutics Group.
What companies has Helen Liang invested in?
Investments tracked here include 1910 Genetics, Alinea, Arintra, Cognito TX, Jeeves, Jericho Security, Kapital, Kernal Bio, Linvest21.ai, Meru Health, Nitra, Salt Security, and 3 more.
Where did Helen Liang go to school?
Helen Liang studied at Harvard Business School (Corporate Board Executive Program); Stanford University Graduate School of Business (Executive Program, Leadership Development); Harvard Business School (Executive Program, Building a Legacy: Family Office Wealth Management).

Same school

Shared employers